Neisseria meningitidis: an overview of the carriage state, p.438 ,
, J Med Microbiol, vol.53, pp.821-853, 2004.
Meningococcal carriage and disease--population biology and 440 evolution, Vaccine, vol.27, issue.2, pp.64-70, 2009. ,
, Meningococcal vaccines, vol.15, pp.155-69, 2001.
Classification and pathogenesis of meningococcal 444 infections, Methods Mol Biol, vol.799, pp.21-35, 2012. ,
, , p.446
,
,
Changes in Neisseria meningitidis disease epidemiology in the 449 ,
, United States, 1998-2007: implications for prevention of meningococcal disease, Clin Infect, p.450
, Dis, vol.50, issue.2, pp.184-91, 2010.
Prospects for eradication of meningococcal disease, Arch Dis Child, vol.97, issue.11, pp.993-1001, 2012. ,
, , p.454
, , p.485
, Therapy in Genotype ST-11 Meningococcal Infections, vol.32, pp.291-486, 2013.
Corticosteroids for 488 treating sepsis, Cochrane Database Syst Rev, issue.12, p.2243, 2015. ,
,
Transgenic mice expressing human transferrin as a model for 491 meningococcal infection, Infect Immun, vol.75, issue.12, pp.5609-5623, 2007. ,
Iron transport systems in Neisseria 493 meningitidis, Microbiol Mol Biol Rev, vol.68, issue.1, pp.154-71, 2004. ,
Impact of corticosteroids 495 on experimental meningococcal sepsis in mice, Steroids, vol.101, pp.96-102, 2015. ,
,
, Emergence of new virulent Neisseria meningitidis, p.498
URL : https://hal.archives-ouvertes.fr/pasteur-02085474
, serogroup C sequence type 11 isolates in France, J Infect Dis, vol.202, issue.2, pp.247-50, 2010.
Lipocalin 2 in cerebrospinal fluid 500 as a marker of acute bacterial meningitis, BMC Infect Dis, vol.14, issue.1, p.276, 2014. ,
, , p.502
Complement deficiency states and meningococcal 557 disease, Immunol Res, vol.12, issue.3, pp.295-311, 1993. ,
CD46 accelerates macrophage-559 mediated host susceptibility to meningococcal sepsis in a murine model, Eur J Immunol, vol.47, issue.1, pp.119-130, 2017. ,
The role of the glucocorticoid receptor in inflammation and 562 immunity, J Steroid Biochem Mol Biol, vol.120, issue.2-3, pp.69-75, 2010. ,
The five Rs of glucocorticoid action during inflammation: 564 ready, reinforce, repress, resolve, and restore, Trends Endocrinol Metab, vol.24, issue.3, pp.109-128, 2013. ,
, , p.566
, , p.567
, Glucocorticoid receptor dimerization is required for survival in septic shock via suppression 568 of interleukin-1 in macrophages, FASEB J, vol.26, issue.2, pp.722-731, 2012.
Protective and pathogenic functions of macrophage subsets, p.570 ,
, Nat Rev Immunol, vol.11, issue.11, pp.723-760, 2011.
Nonresolving inflammation, Cell, vol.140, issue.6, pp.871-82, 2010. ,
Control of pro-inflammatory cytokine release from human 573 monocytes with the use of an interleukin-10 monoclonal antibody, Methods Mol Biol, p.1172 ,